Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients—A Proof-of-Principle Trial

OBJECTIVES: Renal replacement therapy in coronavirus disease 2019 patients is complicated by increased activation of the coagulation system. This may worsen the quality of hemodialysis and contribute to a shortage of dialysis machines as well as plastic disposables during the pandemic. This study de...

Descripción completa

Detalles Bibliográficos
Autores principales: Neumann-Haefelin, Elke, Widmeier, Eugen, Bansbach, Joachim, Kaufmann, Kai, Heinrich, Sebastian, Walz, Gerd, Bürkle, Hartmut, Kalbhenn, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314355/
https://www.ncbi.nlm.nih.gov/pubmed/32696014
http://dx.doi.org/10.1097/CCE.0000000000000155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314355/
https://www.ncbi.nlm.nih.gov/pubmed/32696014
http://dx.doi.org/10.1097/CCE.0000000000000155

Ejemplares similares